Table 3. Unadjusted analyses of the association between sub-clinical hepatotoxicity with different demographic and clinical variables, Addis Ababa, August 2004-March 2005.
Variable | Status | OR (95% CI ) |
HIV status | Positive | 3.6 (1.5–8.5) |
Negative | 1.0 | |
Sex | Female | 1.8 (.8–3.8) |
Male | 1.0 | |
Age | >35 | 1.1 (.48–2.4) |
<35 | 1.0 | |
BMI | ≥18.5 | 0.7 (.3–1.5) |
<18.5 | 1.0 | |
Concomitant drug intake | No | 0.4 (.2–.9) |
Yes | 1.0 | |
HbsAg | Negative | 0.7 (.2–2.5) |
Positive | 1.0 | |
Anti-HCV Ab | Negative | 1.0 (0.9–1.0) |
Positive | 1.0 | |
CD4 count/mm3 | 0–50 | 21.3 (2.2–204.9) |
51–100 | 5.2 (0.6–46.0) | |
101–200 | 4.3 (0.4–42.4) | |
>200 | 1.0 |